Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:603-609
Published online before print February 9, 2004, doi: 10.1161/01.HYP.0000118053.42262.71
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/3/603    most recent
01.HYP.0000118053.42262.71v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuda, H.
Right arrow Articles by Saruta, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuda, H.
Right arrow Articles by Saruta, T.
Related Collections
Right arrow ACE/Angiotension receptors

(Hypertension. 2004;43:603.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Role of Endothelium-Derived Hyperpolarizing Factor in ACE Inhibitor-Induced Renal Vasodilation in Vivo

Hiroto Matsuda; Koichi Hayashi; Shu Wakino; Eiji Kubota; Masanori Honda; Hirobumi Tokuyama; Ichiro Takamatsu; Satoru Tatematsu; Takao Saruta

From the Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.

Correspondence to Dr Koichi Hayashi, Department of Internal Medicine School of Medicine, Keio University, 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582, Japan. E-mail khayashi{at}sc.itc.keio.ac.jp

Although the angiotensin-converting enzyme (ACE) inhibitor-induced bradykinin enhances nitric oxide (NO) release, bradykinin may also stimulate the production of an additional vasodilator, endothelium-derived hyperpolarizing factor (EDHF). This study examined the role of EDHF in mediating the NO-independent action of ACE inhibitors in canine renal microcirculation in vivo. We used intravital CCD camera videomicroscopy that allowed direct visualization of renal microcirculation in superficial and juxtamedullary nephrons in an in vivo, in situ, and relatively intact setting. In the presence of E4177 (an angiotensin receptor blocker), cilazaprilat (30 µg/kg) had no effect on diameter of superficial afferent arterioles (Aff), but it increased renal contents of bradykinin and nitrate plus nitrite, and it elicited dilation of juxtamedullary Aff (from 24.0±0.2 to 28.2±0.8 µm), juxtamedullary efferent arterioles (Eff) (from 24.2±0.2 to 28.0±0.8 µm), and superficial Eff (from 18.2±0.2 to 19.7±0.2 µm). These changes in diameters were prevented by N{alpha}-adamantaneacetyl-D-Arg-[Hyp3,Thi5,8,D-Phe7]bradykinin, a bradykinin receptor antagonist. The pretreatment with nitro-L-arginine methylester (L-NAME) plus E4177 eliminated the dilator response of juxtamedullary/superficial Eff and the increase in renal nitrate plus nitrite levels induced by cilazaprilat. In contrast, in the presence of E4177+L-NAME, cilazaprilat still caused 8%±3% dilation of juxtamedullary Aff, which was completely eliminated by proadifen, a cytochrome-P450 and KCa channel blocker. Collectively, the ACE inhibitor exerts multiple vasodilator mechanisms, including the inhibition of angiotensin II formation; blockade of angiotensin II activity appears to be a dominant mechanism in superficial Aff, whereas the bradykinin-induced NO acts on superficial Eff and juxtamedullary Aff/Eff. Furthermore, a putative EDHF is an additional mechanism for the ACE inhibitor-induced vasodilation of juxtamedullary Aff in vivo.


Key Words: angiotensin-converting enzyme • bradykinin • endothelium-derived factors • arterioles • nitric oxide




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
G. A. Eppel, D. L. Jacono, M. Shirai, K. Umetani, R. G. Evans, and J. T. Pearson
Contrast angiography of the rat renal microcirculation in vivo using synchrotron radiation
Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1023 - F1031.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Fitzgerald, H. Bashari, J. A. Cox, H. C. Parkington, and R. G. Evans
Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1072 - H1082.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. G. Salom, B. Arregui, L. F. Carbonell, F. Ruiz, J. L. Gonzalez-Mora, and F. J. Fenoy
Renal ischemia induces an increase in nitric oxide levels from tissue stores
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1459 - R1466.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Imig
ACE Inhibition and Bradykinin-Mediated Renal Vascular Responses: EDHF Involvement
Hypertension, March 1, 2004; 43(3): 533 - 535.
[Full Text] [PDF]